Ryan Geschwindt
Impact in
-
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
- Cytokine Signaling Pathways and Interactions 2
- CAR-T cell therapy research 2
-
- Lung Cancer Treatments and Mutations 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Niranjan Y. Sardesai (2 shared papers)Harvey I. Pass (1 shared paper)Michael Craig Miller (1 shared paper)W. Jeffrey Allard (1 shared paper)Ingegerd Hellström (1 shared paper)Thorsten Verch (1 shared paper)Lý Thị Trần (1 shared paper)Curtis L. Glover (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)British Journal of Cancer (1 paper)Clinical Chemistry (1 paper)Oncotarget (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Ryan Geschwindt
15 papers receiving 331 citations
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 137
- Oncology 80
- Cancer Research 37
- Biological Psychiatry 5
- Genetics 47
Countries citing papers authored by Ryan Geschwindt
This map shows the geographic impact of Ryan Geschwindt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Geschwindt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Geschwindt more than expected).
Fields of papers citing papers by Ryan Geschwindt
This network shows the impact of papers produced by Ryan Geschwindt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Geschwindt. The network helps show where Ryan Geschwindt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Geschwindt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 110 | |
| 2 | 2005 | 54 | |
| 3 | 2018 | 35 | |
| 4 | 2007 | 30 | |
| 5 | 2016 | 22 | |
| 6 | 2016 | 21 | |
| 7 | 2023 | 19 | |
| 8 | 2001 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 3 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2013 | 1 |
About Ryan Geschwindt
Ryan Geschwindt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Epidemiology, having authored 15 papers that have together received 337 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (137 citations), Oncology (80 citations), Cancer Research (37 citations), Biological Psychiatry (5 citations) and Genetics (47 citations). Ryan Geschwindt has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Niranjan Y. Sardesai, Harvey I. Pass, Michael Craig Miller, W. Jeffrey Allard, Ingegerd Hellström, Thorsten Verch, Lý Thị Trần, Curtis L. Glover, Robert Iannone and Sara M. Federico. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Chemistry, Oncotarget and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.